sabina eigenbrod
sabina eigenbrod
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Quantifying prion disease penetrance using large population control cohorts
EV Minikel, SM Vallabh, M Lek, K Estrada, KE Samocha, ...
Science translational medicine 8 (322), 322ra9-322ra9, 2016
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
J Felsberg, N Thon, S Eigenbrod, B Hentschel, MC Sabel, M Westphal, ...
International journal of cancer 129 (3), 659-670, 2011
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, ...
Neuro-oncology 13 (3), 307-316, 2011
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
A Pfeifer, S Eigenbrod, S Al-Khadra, A Hofmann, G Mitteregger, M Moser, ...
The Journal of clinical investigation 116 (12), 3204-3210, 2006
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
NL Jansen, V Graute, L Armbruster, B Suchorska, J Lutz, S Eigenbrod, ...
European journal of nuclear medicine and molecular imaging 39, 1021-1029, 2012
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ...
Neurology 84 (7), 710-719, 2015
Low values of 5‐hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors
TFJ Kraus, D Globisch, M Wagner, S Eigenbrod, D Widmann, M Münzel, ...
International journal of cancer 131 (7), 1577-1590, 2012
Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma
NL Jansen, B Suchorska, V Wenter, C Schmid-Tannwald, A Todica, ...
Journal of Nuclear Medicine 56 (1), 9-15, 2015
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients
NL Jansen, B Suchorska, V Wenter, S Eigenbrod, C Schmid-Tannwald, ...
Journal of Nuclear Medicine 55 (2), 198-203, 2014
O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation
S Kreth, N Thon, S Eigenbrod, J Lutz, C Ledderose, R Egensperger, ...
PloS one 6 (2), e17156, 2011
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
NL Jansen, C Schwartz, V Graute, S Eigenbrod, J Lutz, R Egensperger, ...
Neuro-oncology 14 (12), 1473-1480, 2012
IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival
N Thon, S Eigenbrod, S Kreth, J Lutz, JC Tonn, H Kretzschmar, A Peraud, ...
Cancer 118 (2), 452-460, 2012
Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health …
N Thon, S Eigenbrod, EM Grasbon-Frodl, M Ruiter, JH Mehrkens, S Kreth, ...
Journal of Neuropathology & Experimental Neurology 68 (11), 1219-1228, 2009
Dynamic 18F‐FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses
N Thon, M Kunz, L Lemke, NL Jansen, S Eigenbrod, S Kreth, J Lutz, ...
International journal of cancer 136 (9), 2132-2145, 2015
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients
S Eigenbrod, R Trabold, D Brucker, C Erös, R Egensperger, ...
Acta neurochirurgica 156, 1427-1440, 2014
Cerebral angiitis in four patients with chronic GVHD
P Sostak, CS Padovan, S Eigenbrod, S Roeber, S Segerer, C Schankin, ...
Bone marrow transplantation 45 (7), 1181-1188, 2010
ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients
SA Adam, O Schnell, J Pöschl, S Eigenbrod, HA Kretzschmar, JC Tonn, ...
Brain pathology 22 (6), 788-797, 2012
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide
N Thon, S Eigenbrod, EM Grasbon-Frodl, J Lutz, S Kreth, G Popperl, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 441-446, 2011
MiRNA expression patterns predict survival in glioblastoma
M Niyazi, F Zehentmayr, OM Niemöller, S Eigenbrod, H Kretzschmar, ...
Radiation Oncology 6, 1-8, 2011
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status
M Niyazi, O Schnell, B Suchorska, SB Schwarz, U Ganswindt, J Geisler, ...
Radiotherapy and Oncology 104 (1), 78-82, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20